Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 10Thoracic 4Gynecologic 3Sarcoma 1NET 1Head & Neck 1Endocrine 1Dermatologic 1Breast 1

Conditions

Sarcoma 190Osteosarcoma 73Sarcoma, Ewing 50Rhabdomyosarcoma 45Melanoma 40Neuroblastoma 36Gastrointestinal Stromal Tumors 35Neoplasms 33Colorectal Neoplasms 29Bone Neoplasms 29Glioblastoma 28Neoplasm Metastasis 27Ovarian Neoplasms 25Breast Neoplasms 25Wilms Tumor 22Gliosarcoma 22Glioma 22Rhabdoid Tumor 21Lymphoma, Non-Hodgkin 21Sarcoma, Kaposi 20Liposarcoma 20Carcinoma, Non-Small-Cell Lung 20Hepatoblastoma 19Pancreatic Neoplasms 18Neurofibrosarcoma 18Medulloblastoma 18Carcinoma, Renal Cell 18Lymphoma 17Desmoid Tumors 17Thyroid Neoplasms 16

Interventions

repotrectinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Intestinal Neoplasms × Sarcoma × 90 days × Clear all
NCT03093116 2026-05-27

TRIDENT-1

Turning Point Therapeutics, Inc.

Phase 1/2 Recruiting
500 enrolled 2 FDA
EndocrineGastrointestinalHead & NeckNETSarcomaThoracic

Adenocarcinoma, Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Colonic Diseases, Colonic Neoplasms, Digestive System Neoplasms, Endocrine System Diseases, Endocrine Gland Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Sarcoma, Thoracic Neoplasms, Thyroid Diseases, Thyroid Neoplasms, Neuroectodermal Tumors, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡